健民集團(600976.SH):2020年淨利升61.53%至1.48億元 擬10派3.66元
格隆匯3月15日丨健民集團(600976.SH)披露2020年年度報吿,實現營業收入24.56億元,同比增長9.69%;歸屬於上市公司股東的淨利潤1.48億元,同比增長61.53%;歸屬於上市公司股東的扣除非經常性損益的淨利潤1.38億元,同比增長65.65%;基本每股收益0.96元,擬向全體股東每10股派發現金紅利3.66元(含税)。
2020年公司營業收入同比增長9.69%,其中醫藥工業的營業收入同比增長5.95%,醫藥商業的營業收入同比增長13.37%。醫藥工業收入的增長主要是母公司營業收入同比增長12.51%,報吿期內公司大力推行精益生產,控制成本,提升品質,加強品牌建設、渠道推廣、優化銷售策略,實現龍牡壯骨顆粒等主導產品收入增加。醫藥商業收入的增長主要是福高公司、維生公司加大新品種開發力度、積極佈局新業務實現的收入增長。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.